These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36761066)

  • 41. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines.
    Mann D; Reynolds K; Smith D; Muntner P
    Ann Pharmacother; 2008 Sep; 42(9):1208-15. PubMed ID: 18648016
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimal Low-Density Lipoprotein Cholesterol Levels in Adults Without Diabetes Mellitus: A Nationwide Population-Based Study Including More Than 4 Million Individuals From South Korea.
    Huh JH; Park SW; Go TH; Kang DR; Lee SH; Kim JY
    Front Cardiovasc Med; 2021; 8():812416. PubMed ID: 35127872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statins, low-density lipoprotein cholesterol, and risk of cancer.
    Alsheikh-Ali AA; Trikalinos TA; Kent DM; Karas RH
    J Am Coll Cardiol; 2008 Sep; 52(14):1141-7. PubMed ID: 18804740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: the CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) study.
    Ur E; Langer A; Rabkin SW; Calciu CD; Leiter LA;
    Can J Cardiol; 2010 Feb; 26(2):80-6. PubMed ID: 20151053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium.
    Norby FL; Eryd SA; Niemeijer MN; Rose LM; Smith AV; Yin X; Agarwal SK; Arking DE; Chasman DL; Chen LY; Eijgelsheim M; Engström G; Franco OH; Heeringa J; Hindy G; Hofman A; Lutsey PL; Magnani JW; McManus DD; Orho-Melander M; Pankow JS; Rukh G; Schulz CA; Uitterlinden AG; Albert CM; Benjamin EJ; Gudnason V; Smith JG; Stricker BH; Alonso A
    PLoS One; 2016; 11(3):e0151932. PubMed ID: 26999784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study.
    Lee CJ; Park S; Han K; Lee SH
    J Am Heart Assoc; 2022 May; 11(9):e024379. PubMed ID: 35470675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin use and recurrence of atrial fibrillation after successful cardioversion.
    Humphries KH; Lee M; Sheldon R; Ramanathan K; Dorian P; Green M; Kerr CR;
    Am Heart J; 2007 Nov; 154(5):908-13. PubMed ID: 17967597
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuation of statin therapy and a decreased risk of atrial fibrillation/flutter in patients with and without chronic kidney disease.
    Chang CH; Lee YC; Tsai CT; Chang SN; Chung YH; Lin MS; Lin JW; Lai MS
    Atherosclerosis; 2014 Jan; 232(1):224-30. PubMed ID: 24401243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum lipoprotein levels, statin use, and cognitive function in older women.
    Yaffe K; Barrett-Connor E; Lin F; Grady D
    Arch Neurol; 2002 Mar; 59(3):378-84. PubMed ID: 11890840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between the APOE gene polymorphism and lipid profile and the risk of atrial fibrillation.
    Deng X; Hou J; Deng Q; Zhong Z
    Lipids Health Dis; 2021 Sep; 20(1):123. PubMed ID: 34587962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statin Dosing Instructions, Medication Adherence, and Low-Density Lipoprotein Cholesterol: a Cohort Study of Incident Statin Users.
    Marcum ZA; Huang HC; Romanelli RJ
    J Gen Intern Med; 2019 Nov; 34(11):2559-2566. PubMed ID: 31367867
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users.
    Sung KC; Huh JH; Ryu S; Lee JY; Scorletti E; Byrne CD; Kim JY; Hyun DS; Ko SB
    J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin resistance is associated with increased cholesterol synthesis, decreased cholesterol absorption and enhanced lipid response to statin therapy.
    Hoenig MR; Sellke FW
    Atherosclerosis; 2010 Jul; 211(1):260-5. PubMed ID: 20356594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study.
    Choi J; Lee SR; Choi EK; Ahn HJ; Kwon S; Park SH; Lee H; Chung J; Han M; Lee SW; Han KD; Oh S; Lip GYH
    Front Cardiovasc Med; 2022; 9():832023. PubMed ID: 35402530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
    Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
    Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
    Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
    J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mildly Abnormal Lipid Levels, but Not High Lipid Variability, Are Associated With Increased Risk of Myocardial Infarction and Stroke in "Statin-Naive" Young Population A Nationwide Cohort Study.
    Park JB; Kim DH; Lee H; Hwang IC; Yoon YE; Park HE; Choi SY; Kim YJ; Cho GY; Han K; Kim HK
    Circ Res; 2020 Mar; 126(7):824-835. PubMed ID: 31978313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort.
    Oni-Orisan A; Hoffmann TJ; Ranatunga D; Medina MW; Jorgenson E; Schaefer C; Krauss RM; Iribarren C; Risch N
    Circ Genom Precis Med; 2018 Sep; 11(9):e002043. PubMed ID: 30354326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.